The Predictive Role of New Markers in Early Diagnosis of Acute Kidney Injury in Patients with Acute Pancreatitis

Objective: Acute Kidney Injury (AKI) is a serious early complication that significantly increases the mortality rate in patients with acute pancreatitis (AP). AKI can improve with an early diagnosis and appropriate treatment protocols. We aimed to evaluate the role of IL-6, IL-18, NGAL, IL-1β, TNF-α, Cys-C and KIM-1 in serum and IL-18 in urine in the early detection of AKI in patients with AP. Materials and Methods: Fifty-six patients, who were diagnosed with AP and underwent standard treatment, between July 2011 and December 2013, were included in the study. Patients were sampled for markers at admission and discharge, or when the patients died. Patients were grouped by presence or absence of AKI. Results: The mean age of the cases was 56.41 ± 20.23 (17 91), of which 21 (37.5%) of the cases were male and 35 (62.5%) were female. AKI was detected in 13 (23.2%) patients. The Cys-C level was significantly higher in AKI patients (at hospitalization p < 0.01). Cys-C levels at hospitalization were significantly higher than discharge levels (p < 0.05). Serum KIM-1 level of patients with AKI was higher than the patients without AKI during admission (p < 0.05). There was a positive correlation between serum KIM-1 and creatinine, but a negative correation between GFR and spot urine amylase/creatinine ratio during AKI patients’ admission (respectively; p < 0.05, p < 0.05, p < 0.05). Conclusion: In this study, Cys-C and KIM-1 proved to be statistically significant to predict AKI in patients with AP. However further studies are required to support these conclusions. How to cite this paper: Karagöz, F., Şit, D., Kırankaya, A., Aker Karagöz, Y., Savaş, A., İpek, Y., Esen Atay, B. and Atay, A.E. (2020) The Predictive Role of New Markers in Early Diagnosis of Acute Kidney Injury in Patients with Acute Pancreatitis. Open Journal of Nephrology, 10, 254-263. https://doi.org/10.4236/ojneph.2020.103025 Received: July 3, 2020 Accepted: September 5, 2020 Published: September 8, 2020 Copyright © 2020 by author(s) and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access


Introduction
Acute pancreatitis (AP) is a frequent clinical table with high morbidity and mortality rates, and can result in multiple organ dysfunction including acute kidney injury (AKI) [1] [2]. Acute pancreatitis-related mortality is usually due to systemic inflammatory response syndrome (SIRS) and organ failure in the first two weeks, sepsis and complications afterwards and varies between 12% -47% according to clinical severity [3] [4]. Mortality rates are related to the AKI stage [5] [6] [7] [8] [9]. Early diagnosis and treatment of AKI are most important in preventing morbidity and mortality. The diagnosis of AKI is usually based on serum creatinine (SCr) levels; however, there are some diagnostic difficulties such as the late rise of the SCr level, sex, age and nutritional status. Therefore, some biomarkers are being studied for an earlier AKI diagnosis. Interleukin (IL)-1β, IL-6, IL-18, kidney injury molecule-1 (KIM-1), tumor necrosis factor (TNF)-α, serum cystatin C (CYS-C), and neutrophil gelatinase-related lipocalin (NGAL) showed the importance of different biomarkers in different patient populations [10]- [18].
In this study, we evaluated the efficacy of IL-1β, IL-6, IL-18, KIM-1, TNF-α, Cys-C, NGAL in serum and IL-18 in urine biomarkers in the early diagnosis of AKI in patients with AP.

Patients
Fifty-six patients who were diagnosed with acute pancreatitis according to diagnostic criteria for acute pancreatitis in Practice Guidelines for Acute Pancreatitis in İnternal Medicine Clinic of Bağcılar Training and Research Hospital were included in this study [19]. Among these patients, those with chronic kidney diseases, those on a program of chronic hemodialysis or peritoneal dialysis, those with acute inflammation other than AP and patients refusing treatment for various reasons or refusing to participate in the study were excluded.
The study was approved by the Bağcılar Training and Research Hospital Non-Invasive committee and was conducted between July 2011 and December 2013. Informed consent was taken from the patients. Helsinki Declaration principles were provided. The level of discharge SCr was accepted as the baseline level. The difference between admission SCr level and discharge level was evaluated according to Kidney Disease Improving Global Outcomes (KDIGO) criteria and AKI was diagnosed. According to the KDIGO criteria, AKI was defined as at least 50% increase in serum creatinine level within seven days or as an increase of 0.3 mg/dL (26.5 micromoles/L) or more within two days or as a urine Open Journal of Nephrology output <0.5 mL/kg/h for at least six or twelve hours or <0.3 ml/kg/h for twenty-four hours [20]. It was confirmed that renal failure was intrinsic by parameters such as imaging methods, biochemical analyses, fractionated sodium excretion (FE NA ) and renal failure index. Blood and urine samples for IL-18, high sensitive C reactive protein (hs-CRP), Cys-C, IL-6, IL-1β, TNF-α, KIM-1, NGAL, routine biochemistry, urine and complete blood count tests for AKI and AP were taken at admission and discharge from all patients. Patients were grouped by presence or absence of AKI.

Statistical Analysis
Statistical Package for Social Sciences (SPSS) for Windows 15.0 program was used for analyzing results statistically. Kolmogorov-Smirnov test was used for normal distribution suitability of parameters. Student t test for normal distribution of the parameters between two groups of comparisons, Mann Whitney U test for comparison between two groups of parameters with no normal distribution for descriptive statistical methods (Mean, Standard deviation) as well as the comparison of quantitative data were used while evaluating the data. Paired sample t test was used for in-group comparisons of normal distribution parameters, Wilcoxon sign test for in-group comparisons of parameters with no normal distribution. Fisher's Exact Chi-Square test was used for the comparison of qualitative data. Logistic regression analysis was used to evaluate how one or more independent variables affect the dependent variable separately and together.
Significance was evaluated at p < 0.05.

Results
The mean age of the cases was 56.41 ± 20.23 (17 -91), of which 21 (37.5%) of the cases were male and 35 (62.5%) were female. Mean age was significantly higher in the AKI group than in non-AKI group (p < 0.05). AKI was developed in 13 (23.2%) cases. Renal replacement therapy was needed in only one patient. We detected that AKI was at stage 1 in five patients according to KDIGO criteria, stage 2 in three patients and stage 3 in five patients.
Serum parameters related with AP and AKI according to renal failure are shown in Table 1.

F. Karagöz et al. Open Journal of Nephrology
In the present study, patients diagnosed with AKI presented FE Na and kidney failure index values above 1% and no signs of obstruction on the ultrasound studies suggesting AKI to be caused by intrinsic renal damage in all cases.
The Cys-C levels at admission and discharge of patients with AKI were significantly higher than those without AKI (respectively; p < 0.05, p < 0.01). In cases with and without kidney injury, the decrease in discharge Cys-C levels relative to the admission Cys-C levels was significant (respectively; p < 0.05, p < 0.05). The serum NGAL and IL-6 levels at the discharge of patients with AKI were significantly higher than without AKI (respectively; p < 0.05, p < 0.05). Although there was no significant change in the levels of serum IL-6 and TNF-α of patients with AKI, there was significant, respectively, decrease and increase in patients without AKI (respectively; p < 0.01, p < 0.01). It was determined that there was significant difference between the serum KIM-1 levels at admission of patients with and without AKI (respectively; p < 0.05, p < 0.05). The other results of serum and urine biomarkers are shown in Table 2.  Both spot urine and 24-hours urine protein levels at the discharge of patients with AKI were significantly higher than without AKI (respectively; p < 0.05, p < 0.05). In cases without AKI the decrease in discharge levels of spot and 24-hours urine protein relative to the admission levels of spot and 24-hours urine protein was significant (respectively; p < 0.05, p < 0.01).

F. Karagöz et al. Open Journal of Nephrology
Parameters between AKI and non-AKI groups at admission were examined at logistic regression analysis. As a result of univariate logistic regression analysis, risk factors affecting AKI were examined. As a result of these analyzes, Cys-C and IL-18 variables with p values below 0.25 were included in the multivariate logistic regression analysis. Considering the univariate regression analysis results, an increase in Cys-C value by one unit increases the risk of developing AKI by 1.002 times. As a result of multivariate logistic regression analysis, only Cys-C was found to be significant and remained in the model. Logistic regression analysis results are shown in Table 3 and Table 4.

Discussion
Acute pancreatitis, especially a moderate or severe form, is associated with multisystem complications. AP can increase rates of morbidity and mortality and complicated AP can result in higher rates. Early diagnosis of AKI which is the one of most common complications of AP, has significant impact on the rates of morbidity and mortality.  Kim et al. found that plasma NGAL levels were significantly higher in patients with sepsis with AKI than in those without AKI [15]. Pickering and Endre found that an increase in the level of plasma NGAL was significant for detecting AKI in patients with both functional and structural AKI, with more significant in structural AKI [16]. Lin et al. found that APACHE III score, serum IL-18 and Cys-C levels on the first day of renal replacement therapy in patients with AKI, who were transferred to the ICU, were the independent predictors of mortality [18].
Tsigou et al. reported that NGAL, Cys-C, KIM-1, IL-18, and L-FABP were more effective for detecting AKI pior to elevation of the SCr level [25].   Cys-C is an extracellular cysteine protease inhibitor, which is filtered from the glomeruli and reabsorbed from the proximal tubules. In contrast to SCr, blood levels are not affected by factors such as age, gender, muscle mass and race [17].
Cys-C has been recognized as an early predictor of AKI and an independent indicator of mortality [26] [27] [28]. KIM-1 is a type-1 cell membrane protein produced in proximal tubular epithelial cells that increases in AKI, fibrosis, renal cell carcinoma, and polycystic kidney disease. Two systematic reviews have reported that KIM-1 is a novel biomarker that is effective in diagnosing AKI within 24 hours of kidney injury, especially in ischemic acute tubular necrosis [29] [30]. In critically ill patients, the use of Cys-C for the prediction of AKI was in- The present study has some potential drawbacks. First, the sample number in our study was relatively low which may affect the significance of the results. We collected samples only at admission and discharge. Serial measurement of biomarkers may provide more valuable data. We do not know baseline SCr levels; we accepted baseline serum creatinine values as acute pancreatitis was healed. As the present study has not included post discharge clinical follow-up, continued kidney function recovery may have led to lower post discharge creatinine clearance values eventually reaching the basal creatinine clearance values which were not available at the patients' admission. Therefore, in the diagnosis of AKI in patients with AP, the diagnostic value of KIM-1 and Cys-C needs to be verified with studies to be conducted with a larger sample.

Conclusion
Many urines and serum markers are being evaluated due to inadequate early detection of serum creatinine in AKI. Among these, serum NGAL and Cys-C are the most studied. In our study, Cys-C and KIM-1 appear to be helpful in the early diagnosis of AKI in patients with acute pancreatitis. However, it seems that there is a need for large-scale and long-term studies to obtain clearer data.

Supporting Organizations
In this study the Bağcılar Training and Research Hospital working capital fund support was obtained.